STUDY ON CARDIAC MANIFESTATIONS IN CKD PATIENTS IN A TEACHING HOSPITAL

VINAYAK INKALAGI; PRIYANKA KATTI B

doi:10.22159/ajpcr.2023.v16i12.49833

Authors

VINAYAK INKALAGI Department of General Medicine, Al Ameen Medical College, Bijapur, Karnataka, India.
PRIYANKA KATTI B Department of Obstetrics and Gynaecology, Belgaum Institute of Medical Sciences, Belagavi, Karnataka, India.

DOI:

https://doi.org/10.22159/ajpcr.2023.v16i12.49833

Keywords:

Chronic kidney disease, Echocardiography, Left ventricular hypertrophy

Abstract

Objective: The aim of the study was to study cardiac manifestations in CKD.

Methods: The study involved 140 instances of CKD that were admitted to the general medicine department of Al Ameen Medical College in Bijapur, Karnataka.

Results: According to our study, there were 31.4% (44/140) instances of left ventricular hypertrophy (LVH), 13.5% (19/140) of LAD, 18.1% (20/140) of conduction abnormalities, 15.7% (22/140) of ischemia, 2.1% (3/140) of arrhythmias, 2.8% (4/140) of P-mitrale, and 21.4% (30/140) of normal cases.

Conclusion: Echocardiography is a non-invasive, secure, user-friendly, and precise method for evaluating heart function in patients with chronic renal disease. When it comes to identifying LVH, echocardiography is more accurate. When it comes to CKD patients, cardiovascular problems are the main cause of morbidity and death.

Downloads

Download data is not yet available.

References

US Renal Data System. 2002 Annual Data Report, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 2002.

Locatelli F, Marcelli D, Conte F, D’Amico M, Del Vecchio L, Limido A, et al. Cardiovascular disease in chronic renal failure: The challenge continues. Nephrol Dial Transplant 2000;15:69-80.

Kundhal K, Lok CE. Clinical epidemiology of cardiovascular disease in chronic kidney disease. Nephron Clin Pract 2005;101:c47-52.

Hill NR, Fatoba ST, Oke JL, Hirst JA, O’Callaghan CA, Lasserson DS, et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One 2016;11:e0158765.

Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2014:351:1296-305.

Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2014;164:659-63.

Stenvinkel P, Larsson TE. Chronic kidney disease: A clinical model of premature aging. Am J Kidney Dis 2013;62:339-51.

Sulemane S, Panoulas VF, Nihoyannopoulos P. Echocardiographic assessment in patients with chronic kidney disease: Current update. Echocardiography 2017;34:594-602.

Saha M, Faroque MO, Alam KS, Alam MM, Ahmed S. Chronic kidney disease specific cardiovascular risk factors among non dialytic patients with chronic kidney disease stage-V--an experience of a specialized hospital. Bangladesh Med Res Counc Bull 2012;38:18-22.

Ronad G, Shankar A, Kumar R. A clinical study of cardiac manifestations in chronic kidney disease. MedPulse Int J Med 2021;19:35-41.

Adarsh LS, Reddy S, Shetty MS. Asymptomatic cardiac manifestations in CKD: Int J Res Med Sci 2018;6:822-7.

Kumar S, Suman B, Kiran C. A study on diagnosticevaluation of ECG and echo results in CKD patients. J Cardiovasc Dis 2022;13: 2039-51.